Presented by Planned Parenthood {beacon} Healthcare Health Care PRESENTED BY The Big Story FDA panel gives nod to Moderna flu shot The FDA’s independent vaccine advisors voted unanimously 9-0 that the benefits outweigh the risks for Moderna’s mFlusiva shot in people ages 50 to 64 as well as 65 and older. The shot is...
Presented by Planned Parenthood {beacon} Healthcare Health Care PRESENTED BY The Big Story FDA panel gives nod to Moderna flu shot The FDA’s independent vaccine advisors voted unanimously 9-0 that the benefits outweigh the risks for Moderna’s mFlusiva shot in people ages 50 to 64 as well as 65 and older. The shot is...
<iframe src="https://statesidedaily.com/embed/cluster/94d4c5e7080238f5fc653ce2dda2a9d3cc64ad78" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="FDA panel gives nod to Moderna flu shot"></iframe>
